Parathyroid carcinoma: A multicenter review of clinicopathologic features and treatment outcomes

Ear, Nose and Throat Journal

Volumn 83, Issue 7, 2004, Pages 491-494

  Wiseman, Sam M ^a,d   Rigual, Nestor R ^b   Hicks, Wesley L ^b   Popat, Saurin R ^c   Lore, John M ^b   Douglas, Wade G ^b   Jacobson, Michael J ^c   Tan, Dongfeng ^b   Loree, Thom R ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; PARATHYROID CARCINOMA; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 3343001847     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130408300718     Document Type: Review

References (20)

1. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973;31:600-5.
2. de Quervain F. Parastruma maligna aberrata. Deutsche Zeitschrift Fuer Chirurgie 1904;100:334-52.
3. Koea JB, Shaw JH. Parathyroid cancer: Biology and management. Surg Oncol 1999;8:155-65.
4. Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab 2001;86:485-93.
5. Vasef MA, Brynes RK, Sturm M, et al. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: A paraffin immunohistochemical study. Mod Pathol 1999;12:412-16.
6. Cryns VL, Rubio MP, Thor AD, et al. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 1994;78:1320-4.
7. Cryns VL, Thor A, Xu HJ, et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994;330:757-61.
8. Wassif WS, Moniz CF, Friedman E, et al. Familial isolated hyperparathyroidism: A distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 1993;77:1485-9.
9. Wu CW, Huang CI, Tsai ST, et al. Parathyroid carcinoma in a patient with non-secretory pituitary tumor: A variant of multiple endocrine neoplasia type-I? Eur J Surg Oncol 1992;18:517-20.
10. Kakinuma A, Morimoto I, Nakano Y, et al. Familial primary hyperparathyroidism complicated with Wilms' tumor. Intern Med 1994;33:123-6.
11. Miki H, Sumitomo M, Inoue H, et al. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis. Surgery 1996;120:897-901.
12. Christmas TJ, Chapple CR, Noble JG, et al. Hyperparathyroidism after neck irradiation. Br J Surg 1988;75:873-4.
13. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: A National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1999;86:538-44.
14. Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 2001;136:878-85.
15. Fujimoto Y, Obara T, Ito Y, et al. Surgical treatment of ten cases of parathyroid carcinoma: Importance of an initial en bloc tumor resection. World J Surg 1984;8:392-400.
16. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: An update and review. World J Surg 1991;15:738-44.
17. Obara T, Okamoto T, Kanbe M, Iihara M. Functioning parathyroid carcinoma: Clinicopathologic features and rational treatment. Semin Surg Oncol 1997;13:134-41.
18. Favia G, Lumachi F, Polistina F, D'Amico DF. Parathyroid carcinoma: Sixteen new cases and suggestions for correct management. World J Surg 1998;22:1225-30.
19. Hakaim AG, Esselstyn CB, Jr. Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation. Cleve Clin J Med 1993;60:331-5.
20. Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: A collective review. Ann Surg 1969;169:631-40.